Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Keeping Track Feature image
Viltepso for certain DMD patients garnered the PRV for Nippon Shinyaku.

Another approval earned a US rare pediatric disease priority review voucher last week, as the program approaches a possible sunset.

Nippon Shinyaku Co., Ltd.’s Viltepso received a PRV with its 12 August approval for certain patients with Duchenne muscular...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers